The molecular evaluation of thioredoxin (TXN1 & TXN2), thioredoxin reductase 1 (TXNRd1), and oxidative stress markers in a binary rat model of hypo- and hyperthyroidism after treatment with gallic acid.
Gallic acid
hyperthyroidism
hypothyroidism
oxidative stress
thioredoxin
Journal
Drug and chemical toxicology
ISSN: 1525-6014
Titre abrégé: Drug Chem Toxicol
Pays: United States
ID NLM: 7801723
Informations de publication
Date de publication:
Nov 2023
Nov 2023
Historique:
medline:
5
9
2023
pubmed:
1
11
2022
entrez:
31
10
2022
Statut:
ppublish
Résumé
Oxidative stress plays an important role in the pathology of thyroid disorders. This study examined the effect of gallic acid (GA) on the oxidative status and expression of liver antioxidant genes including thioredoxin (TXN1 & TXN2) and thioredoxin reductase1 (TXNRd1) in hypo- and hyperthyroid rat models. Forty-nine male Wistar rats were randomly assigned into seven groups as follows: control group, hypothyroid and hyperthyroid groups respectively induced by propylthiouracil and levothyroxine, hypo- and hyper thyroid-treated groups (where the groups were separately treated with 50 and 100 mg/kg of GA daily, orally). The levels of thyroid hormones and serum oxidative stress markers were evaluated after 5 weeks. The relative expression of TXN1,2 and TXNRd1 genes was measured via real-time qRT-PCR. The mean level of total antioxidant capacity (TAC), malondialdehyde, and uric acid index diminished in the hypothyroid group. Increased TAC reached almost the level of control in hypothyroid groups treated with GA. Elevation of thiol index in the hypothyroid group was observed (
Identifiants
pubmed: 36314079
doi: 10.1080/01480545.2022.2131812
doi:
Substances chimiques
Thioredoxin Reductase 1
EC 1.8.1.9
Antioxidants
0
Gallic Acid
632XD903SP
Immunologic Factors
0
Thioredoxins
52500-60-4
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM